Gómez Almaguer, D., Colunga Pedraza, P. R., Gómez de León, A., Gutiérrez Aguirre, C. H., Cantú Rodríguez, O. G., & Jaime Pérez, J. C. (2019). Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.
Cita Chicago Style (17a ed.)Gómez Almaguer, David, Perla Rocío Colunga Pedraza, Andrés Gómez de León, César Homero Gutiérrez Aguirre, Olga Graciela Cantú Rodríguez, y José Carlos Jaime Pérez. Eltrombopag, Low‐dose Rituximab, and Dexamethasone Combination as Frontline Treatment of Newly Diagnosed Immune Thrombocytopaenia. 2019.
Cita MLA (9a ed.)Gómez Almaguer, David, et al. Eltrombopag, Low‐dose Rituximab, and Dexamethasone Combination as Frontline Treatment of Newly Diagnosed Immune Thrombocytopaenia. 2019.